cobenfy schizophrenia drug news

FDA Approves 1st New Schizophrenia Drug in Decades

New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder

On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of drugs for schizophrenia in more than 30 years.

Reason · 14h

In a Victory for the Free Market, FDA Approves New Schizophrenia Drug

Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical company.

The Hill · 1d

FDA approves new type of schizophrenia drug

The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to a press release. “This drug takes the first new approach to

BioPharma Dive7h

Approval in hand, Bristol Myers sets out to sell first-of-its-kind schizophrenia drug

While momentous, the approval of Cobenfy could also draw attention to an age-old problem in American healthcare: Will insurance barriers keep patients from getting an effective medicine?

WFSU16h

A new kind of drug for schizophrenia promises fewer side effects

A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...

21h

New schizophrenia drug could 'change the lives of millions of people'

British scientists have hailed the US approval of a new drug for schizophrenia, saying it “has the potential to change the ...

Business Wire17h

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of ...

U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results